One-in-Four Women Think Health Influencers are As Reliable as Doctors
A new survey reveals nearly one in four women under 50 consider health influencers as reliable as healthcare providers.
A new survey reveals nearly one in four women under 50 consider health influencers as reliable as healthcare providers.
An analysis of five years of U.S. maternal mortality data reveals significant state-to-state differences in causes of death.
A randomized control trial found that postpartum women treated with nifedipine had a dramatically lower readmission rate than those on labetalol.
A federal judge has paused planned NIH funding cuts, halting a proposed $4 billion reduction from research grants.
A marijuana business trade publication reports that some producers are eyeing cannabis-based treatments for women’s health issues.
A systematic review suggests acupuncture may help manage menopausal insomnia—with few side effects, though the evidence is rated low to moderate.
A retrospective study found that preconception use of GLP-1 medications was associated with reduced risks of several adverse pregnancy outcomes.
A study comparing sisters of women with and without pregnancy complications found that genetic and environmental factors may drive cardiovascular disease risk.
A federal judge temporarily halted Trump’s planned deep NIH funding cuts after attorneys general from 22 states sued to block the move.
An Associated Press overview details how various states are introducing bills to criminalize women for obtaining abortion pills.
Recent studies are examining how hormonal contraceptives affect long-term women’s health.
Emerging discussions about what happens after stopping hormonal birth control spark debate.
A state representative in Oregon took the witness stand to describe her personal experience with inadequate menopause care.
Nearly one in four women under age 50 believe that health influencers are as reliable as healthcare providers.
A small randomized‐control trial found semaglutide cut drinking by 40% in people with alcohol use disorder.
Beyond recreation, cannabis is being evaluated for therapeutic benefits in women’s care.
New techniques in managing maternal blood pressure are emerging.
Cannabis producers are exploring new treatment areas in women’s health.
Research shows the causes of maternal mortality differ widely from state to state.
One blood pressure medication outperformed another, potentially lowering postpartum readmission rates.